Quest PharmaTech Inc.

Company Profile

Sector

Healthcare

Industry

Biotechnology

Employees

N/A

Website

www.questpharmatech.com

Country

Canada

Exchange

TSXV

Edmonton, Canada

Quest PharmaTech Inc., a pharmaceutical company develops targeted cancer therapies in Canada. Its lead product is MAb AR9.6, a theranostic agent for cancer in preclinical development for pancreatic cancer. The company is headquartered in Edmonton, Canada.

Key Stats

52-Week Range

C$0.02C$0.05

Beta-0.30

Trailing P/E0.83

Forward P/EN/A

Trailing EPS0.03

Avg Volume

Earnings & Analyst

Next Earnings2026-09-27

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.